Chengdu Kanghong Pharmaceutical Group Co., Ltd (002773.SZ)

CNY 19.72

(0.15%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 8.52 Billion 7.72 Billion 6.95 Billion 7 Billion 5.82 Billion 5.19 Billion
Total Current Assets 5.3 Billion 4.22 Billion 3.69 Billion 3.96 Billion 3.02 Billion 3.41 Billion
Cash And Short Term Investments 4.7 Billion 3.68 Billion 3.13 Billion 3.32 Billion 2.28 Billion 2.49 Billion
Cash and Cash Equivalents 4.7 Billion 3.58 Billion 2.93 Billion 3.32 Billion 2.28 Billion 2.49 Billion
Short Term Investments -11.74 Million 100 Million 200 Million -2.37 Million -3.47 Million -4.16 Million
Net Receivables 177.93 Million 195.69 Million 221.8 Million 371.13 Million 467.23 Million 451.04 Million
Inventory 403.61 Million 330.96 Million 295.62 Million 239.63 Million 263.14 Million 254.07 Million
Other Current Assets 21.91 Million 17.09 Million 42.3 Million 23.4 Million 11.3 Million 214.58 Million
Total Non-Current Assets 3.22 Billion 3.49 Billion 3.25 Billion 3.03 Billion 2.8 Billion 1.78 Billion
Net PPE 2.4 Billion 2.54 Billion 2.09 Billion 1.78 Billion 1.27 Billion 839.58 Million
Good Will And Intangible Assets 408.94 Million 393.11 Million 351.82 Million 562.24 Million 1.3 Billion 807.48 Million
Good Will - - - 214.83 Million 214.83 Million 214.83 Million
Intangible Assets 408.94 Million 393.11 Million 351.82 Million 347.4 Million 1.09 Billion 592.65 Million
Long-Term Investments 28.52 Million -83.01 Million -182.26 Million 20.72 Million 12.27 Million 13.66 Million
Tax Assets 358.07 Million 486.31 Million 545.65 Million 430 Million 68.97 Million 51.01 Million
Other Non Current Assets 22.01 Million 151.02 Million 449.83 Million 245.29 Million 139.29 Million 70.29 Million
Other Assets - - 1.00 - - 1.00
Total Liabilities 717.76 Million 813.85 Million 851.08 Million 1.24 Billion 1.2 Billion 1.11 Billion
Total Current Liabilities 654.43 Million 693.65 Million 667.37 Million 979.69 Million 747.17 Million 619.96 Million
Account Payables 344.02 Million 409.54 Million 343.13 Million 288.87 Million 240.26 Million 101.78 Million
Tax Payables 35.95 Million 41.06 Million 37.28 Million 74.34 Million 111.31 Million 92.72 Million
Short Term Debt 531.81 Thousand 1.59 Million 2.56 Million 953.39 Thousand 1.46 Million 47.66 Million
Deferred Revenue 239.39 Million 11.15 Million 215.18 Million 18.41 Million 17.5 Million 18.91 Million
Other Current Liabilities 70.47 Million 271.36 Million 106.49 Million 671.45 Million 487.94 Million 451.6 Million
Total Non Current Liabilities 63.33 Million 120.19 Million 183.71 Million 265.64 Million 459.29 Million 490.95 Million
Long-Term Debt 1.47 Million 3.26 Million 4.43 Million 217.68 Million 277.64 Million 342.23 Million
Deferred Revenue Non Current 17.3 Million 23.27 Million 25.51 Million 45.19 Million 59.12 Million 66.33 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 36.59 Million 88.51 Million 151.7 Million 399.24 Thousand 119.83 Million 79.4 Million
Other Liabilities -0.00 - 1.00 1.00 1.00 -
Total Equity 7.81 Billion 6.9 Billion 6.1 Billion 5.75 Billion 4.62 Billion 4.08 Billion
Stock Holders Equity 7.8 Billion 6.9 Billion 6.08 Billion 5.75 Billion 4.62 Billion 4.08 Billion
Common Stock 919.46 Million 919.46 Million 919.46 Million 919.46 Million 873.55 Million 673.53 Million
Retained Earnings 4.38 Billion 3.5 Billion 2.72 Billion 2.49 Billion 3.03 Billion 2.52 Billion
Accumulated other comprehensive income 530.46 Million 497.33 Million 469.13 Million 360.07 Million 337.28 Million 266.59 Million
Common Stock Equity 7.8 Billion 6.9 Billion 6.08 Billion 5.75 Billion 4.62 Billion 4.08 Billion
Capital Lease Obligation 1.47 Million 3.26 Million 4.43 Million 1.05 Million 55.3 Thousand 76.17 Thousand
Total Investments 16.77 Million 16.98 Million 17.73 Million 18.35 Million 8.8 Million 9.49 Million
Total Debt 2.01 Million 4.86 Million 6.99 Million 2 Million 277.64 Million 342.23 Million
Net Debt -4.7 Billion -3.58 Billion -2.93 Billion -3.32 Billion -2 Billion -2.15 Billion

Balance Sheet Charts